The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
Brigham and Women's Hospital · Medical University of South Carolina · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,164
total citations
- FWCI
- 45.72
- Percentile
- 100%
- References
- 43
Citations per year
Authors
13Topics & keywords
Topics
Keywords
- Neprilysin
- Ejection fraction
- Heart failure
- Medicine
- Double blind
- Cardiology
- Angiotensin receptor
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.